Skip to contentP
Prestige Consumer Healthcare Inc.
P
PBHPrestige Consumer Healthcare Inc. Q1 2027 · 10-Q
Revenue$265.71M$265.71M+6.5% vs Q1 2026 Net Income$29.18M$29.18M−38.5% vs Q1 2026 EPS Diluted$0.61$0.61−35.8% vs Q1 2026 Gross Profit$136,188,000−3.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
Operating Cash Flow$70,788,000−10.4% Free Cash Flowderived$67,085,000−14.2% Margins · derivedGross margin51.3%−5.0 pt vs Q1 2026
Operating margin19.8%−9.0 pt vs Q1 2026
Net margin11.0%−8.0 pt vs Q1 2026
ended Jun 30, 2026 · filed Aug 6, 2026 · 37 d after period end